In the current work, we assessed whether Neu4 is the enzyme responsible in vivo for the metabolic bypass of the HexA defect in the mouse model of Tay-Sachs disease by studying mice with a double deficiency of Neu4 and HexA. This evidence concerns the gene NEU4 and Tay-Sachs disease.